Severe combined immunodeficiency
(Redirected from Severe combined immunodeficiency disorder)
Severe Combined Immunodeficiency (SCID) is a rare, genetically inherited disorder that severely impairs the development and functioning of key immune cells - T cells and B cells. Characterized by a broad range of genetic mutations, SCID manifests with a variety of clinical presentations[1]. It primarily affects the antibody response due to defects in B lymphocytes themselves or the inability of T-helper cells to correctly activate B lymphocytes[2]. This dysfunction hampers both 'arms' of the adaptive immune system, owing to defects in one or more genes.
Clinical Manifestation and Prognosis[edit | edit source]
Typically, SCID patients exhibit symptoms of severe bacterial, viral, or fungal infections early in life. Common presentations include interstitial lung disease, chronic diarrhea, and failure to thrive[2]. Recurrent ear infections, Pneumocystis jirovecii pneumonia, and extensive oral candidiasis are other frequent manifestations.
SCID is regarded as the most severe type of primary immunodeficiencies[3] with at least nine different known genes whose mutations can lead to a form of SCID[4]. SCID patients are extremely vulnerable to infectious diseases. They are often colloquially referred to as having 'bubble boy disease' or 'bubble baby disease', as their highly compromised immune system necessitates living in a near-sterile environment, much like David Vetter, who gained fame for this reason.
Without treatment, typically in the form of a successful hematopoietic stem cell transplantation, infants with SCID usually succumb to severe, recurrent infections within their first year of life.
Pathophysiology[edit | edit source]
In SCID, the adaptive immune system, comprising B cells and T cells, is fundamentally impaired. This defect occurs due to mutations in any one of a growing number of identified genes[4]. These mutations disrupt the development and functioning of T cells, B cells, or both, significantly compromising the body's capacity to fight off infections.
The common feature among all forms of SCID is a profound deficiency in T cell function. In some forms, B cells and natural killer (NK) cells may also be affected. For example, in X-linked SCID, one of the most common forms of the disease, the number of B cells is usually normal, but the T cells and NK cells are significantly reduced.
The genetic defects in SCID primarily impact the lymphocyte development, maturation, and signaling processes, leaving affected individuals with few or no functional lymphocytes. As a result, SCID patients lack almost all immune defenses, rendering them extraordinarily susceptible to infections.
Diagnosis[edit | edit source]
Diagnosis of SCID is often suspected in infants presenting with severe recurrent infections, failure to thrive, and a history of early mortality in siblings. Diagnostic tests focus on immunological analysis, including complete blood count with differential and lymphocyte subset enumeration via flow cytometry.
Further genetic testing can identify the specific mutation causing SCID, which can help guide treatment decisions and offer predictive information for family planning. Prenatal and newborn screening for SCID, particularly the T-cell receptor excision circle (TREC) test, is becoming increasingly prevalent and can lead to earlier diagnosis and improved outcomes.
Treatment[edit | edit source]
The mainstay of SCID treatment is hematopoietic stem cell transplantation (HSCT), ideally from a matched sibling donor. This treatment can restore immune function and offers the possibility of a full cure[3].
Gene therapy is another promising avenue of treatment, especially for forms of SCID caused by a single gene defect. This treatment approach involves correcting the genetic defect in the patient's own stem cells, enabling the development of functional immune cells.
While waiting for definitive therapy or when definitive therapy is not possible, prophylactic antibiotics and immunoglobulin replacement therapy can be used to prevent infections. Moreover, rigorous infection control measures are crucial to protect these patients from exposure to pathogens.
See also[edit | edit source]
- Primary immunodeficiency
- David Vetter
- Adaptive immune system
- B cell
- T cell
- Hematopoietic stem cell transplantation
- Gene therapy
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD